All lobbying filings

DB3, LLC (FKA the Daschle Group)

DB3, LLC (FKA the Daschle Group) filed a Q3 report for Fresenius Kabi USA, LLC on October 20, 2026, reporting $50,000 in lobbying income.

Lobbying for Fresenius Kabi USA, LLC · Manufacturer of essential medicines and technologies

As filed: DB3, LLC (FKA THE DASCHLE GROUP) for FRESENIUS KABI USA, LLC.

All filings by DB3, LLC (FKA the Daschle Group) · Everything Fresenius Kabi USA, LLC has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

Illinois

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Issues related to domestic manufacturing of essential medicines; issues related to access to and availability of generic medicines; issues related to IV bag safety.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.